Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 3
1961 3
1962 2
1963 18
1964 12
1965 13
1966 4
1967 11
1968 12
1969 14
1970 13
1971 18
1972 23
1973 30
1974 27
1975 33
1976 26
1977 39
1978 28
1979 38
1980 36
1981 29
1982 27
1983 45
1984 42
1985 37
1986 33
1987 30
1988 32
1989 27
1990 41
1991 25
1992 34
1993 24
1994 26
1995 28
1996 36
1997 24
1998 30
1999 20
2000 20
2001 25
2002 33
2003 24
2004 39
2005 45
2006 37
2007 40
2008 22
2009 31
2010 31
2011 41
2012 40
2013 39
2014 32
2015 37
2016 28
2017 44
2018 36
2019 47
2020 37
2021 29
2022 37
2023 25
2024 25
2025 29
2026 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,788 results

Results by year

Filters applied: . Clear all
Page 1
Convulsions in children.
Carter S, Gold A. Carter S, et al. N Engl J Med. 1968 Feb 8;278(6):315-7. doi: 10.1056/NEJM196802082780606. N Engl J Med. 1968. PMID: 4866891 Review. No abstract available.
Drug-induced lupus.
Miyasaka N. Miyasaka N. Intern Med. 1996 Jul;35(7):527-8. doi: 10.2169/internalmedicine.35.527. Intern Med. 1996. PMID: 8842756 Free article. Review. No abstract available.
Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide.
Wallace SJ. Wallace SJ. Epilepsy Res. 1998 Jan;29(2):147-54. doi: 10.1016/s0920-1211(97)00080-6. Epilepsy Res. 1998. PMID: 9477147 Review.
For myoclonic seizures and epilepsies which are not otherwise specified, valproate seems of proven efficacy. Ethosuximide may be a useful adjunct. The exact place of lamotrigine, which controls some myoclonia and makes them worse in other patients, requires further study. …
For myoclonic seizures and epilepsies which are not otherwise specified, valproate seems of proven efficacy. Ethosuximide may be a us …
[Juvenile absence epilepsy(JAE)].
Hattori H. Hattori H. Ryoikibetsu Shokogun Shirizu. 2002;(37 Pt 6):69-73. Ryoikibetsu Shokogun Shirizu. 2002. PMID: 12483831 Review. Japanese. No abstract available.
[Ethosuximide].
Ichiba M, Kitazawa S. Ichiba M, et al. Nihon Rinsho. 1995 Feb;53 Su Pt 1:915-7. Nihon Rinsho. 1995. PMID: 8753586 Review. Japanese. No abstract available.
Ethosuximide: from bench to bedside.
Gören MZ, Onat F. Gören MZ, et al. CNS Drug Rev. 2007 Summer;13(2):224-39. doi: 10.1111/j.1527-3458.2007.00009.x. CNS Drug Rev. 2007. PMID: 17627674 Free PMC article. Review.
Commonly observed side effects of ethosuximide are dose dependent and involve the gastrointestinal tract and central nervous system. Ethosuximide has been associated with a wide variety of idiosyncratic reactions and with hematopoietic adverse effects. ...
Commonly observed side effects of ethosuximide are dose dependent and involve the gastrointestinal tract and central nervous system. …
The metabolism of ethosuximide.
Millership JS, Mifsud J, Collier PS. Millership JS, et al. Eur J Drug Metab Pharmacokinet. 1993 Oct-Dec;18(4):349-53. doi: 10.1007/BF03190184. Eur J Drug Metab Pharmacokinet. 1993. PMID: 8020533 Review.
The metabolism of the antiepileptic drug ethosuximide (3-ethyl-3-methylpyrollidine-2,5-dione) (I) in animals and humans is reviewed. Chiral aspects of the metabolism of ethosuximide are discussed. Clarification of the precise nature of the hydroxymetabolites of e …
The metabolism of the antiepileptic drug ethosuximide (3-ethyl-3-methylpyrollidine-2,5-dione) (I) in animals and humans is reviewed. …
Ethosuximide dosage regimens.
Buchanan RA, Kinkel AW, Turner JL, Heffelfinger JC. Buchanan RA, et al. Clin Pharmacol Ther. 1976 Feb;19(2):143-7. doi: 10.1002/cpt1976192143. Clin Pharmacol Ther. 1976. PMID: 816588 Clinical Trial.
A study was conducted in 9 children with petit mal epilepsy to compare the plasma levels of ethosuximide after divided daily administration with those after single daily administration. ...No adverse experiences were reported during the study. The data indicate that eth …
A study was conducted in 9 children with petit mal epilepsy to compare the plasma levels of ethosuximide after divided daily administ …
Ethosuximide induced agranulocytosis.
Imai T, Okada H, Nanba M, Kawada K, Kusaka T, Itoh S. Imai T, et al. Brain Dev. 2003 Oct;25(7):522-4. doi: 10.1016/s0387-7604(03)00060-3. Brain Dev. 2003. PMID: 13129598
Agranulocytosis caused by ethosuximide is extremely rare in children. Drug-induced agranulocytosis is an unexpected side effect of a drug, and delay in diagnosis of agranulocytosis can result in a fatal outcome. ...A drug-induced lymphocyte stimulation test was useful for …
Agranulocytosis caused by ethosuximide is extremely rare in children. Drug-induced agranulocytosis is an unexpected side effect of a …
Self-induced seizures.
Green JB. Green JB. Arch Neurol. 1966 Dec;15(6):579-86. doi: 10.1001/archneur.1966.00470180019002. Arch Neurol. 1966. PMID: 4958992 No abstract available.
1,788 results